← Back to CYCN

Cyclerion Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 04/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 04/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
$0$0.9$0.1$0.1$0.2$0$0
−$1.8−$3.2−$1−$0.3−$1.4−$0.7−$1.3−$1.5
−$0.41−$0.76−$0.30−$0.11−$0.56−$0.29−$0.53−$0.62
4.34.23.23.12.62.52.52.5

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.